Celsus Therapeutics Provides Year End 2013 Financial Results And Corporate Highlights
NEW YORK and LONDON, March 24, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX), an emerging growth, development-stage biotech company, today announced its financial results and provided a review of the twelve month period ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.